Description: Hainan Shuangcheng Pharmaceuticals Co., Ltd. researches, develops, manufactures, and markets synthesized peptide drugs and active pharmaceutical ingredients worldwide. It offers somatostatin, thymosin, clindamycin hydrochloride, thymopentin, L-carnitine, uranin hydrobromide, inosine, cyclophosphine adenosine, motidine, scopolamine, and sodium ferulate for injections, as well as vitamin B6. The company was founded in 2000 and is based in Haikou, the People's Republic of China.
Home Page: www.shuangchengmed.com
No. 16 Xingguo Road
Haikou,
570311
China
Phone:
86 898 6863 5601
Officers
| Name | Title |
|---|---|
| Mr. Jianming Li | GM & Non-Independent Director |
| Mr. Xuguang Wang | Chief Financial Officer |
| Mr. Jianlin Yuan | Deputy GM & Non-Independent Director |
| Ms. Wei Zhang | Deputy Gen. Mang. |
| Mr. Xiaofeng Yu | Deputy GM & Sec. of the Board |
| Liang Hong | Marketing Director |
| Dechun Shi | Production Director |
| Minling Xiong | Associate Quality Director |
Exchange: SHE
Country: CN
Currency: Renminbi (¥)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 7.3861 |
| Price-to-Sales TTM: | 13.4814 |
| IPO Date: | 2012-08-08 |
| Fiscal Year End: | December |
| Full Time Employees: | 409 |